middle.news
BlinkLab Boosts FDA Autism Trial with Drexel University Joining Elite U.S. Network
9:42am on Thursday 12th of February, 2026 AEDT
•
Healthcare
Read Story
BlinkLab Boosts FDA Autism Trial with Drexel University Joining Elite U.S. Network
9:42am on Thursday 12th of February, 2026 AEDT
Key Points
Drexel University joins BlinkLab’s FDA 510(k) pivotal autism diagnostic trial
Trial network now includes nine leading U.S. clinical and academic sites
Pilot study showed 83.7% sensitivity and 84.7% specificity, surpassing FDA thresholds
Pivotal trial to enrol approximately 528 children aged 2–11 years
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
BB1
OPEN ARTICLE